IMCHECK THERAPEUTICS
ImCheck Therapeutics is a developer of immuno-modulatory antibodies designed for the treatment of cancer and other immune-related diseases. The company's services are engaged in the discovery and development of immunomodulators for treating breast cancer, gastric, ovarian cancer cells and other solid solid tumours.
IMCHECK THERAPEUTICS
Industry:
Biopharma Biotechnology Health Care Life Science Therapeutics
Founded:
2015-01-01
Address:
Marseille, Provence-Alpes-Cote D'Azur, France
Country:
France
Website Url:
http://www.imchecktherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+33 4 13 96 14 90
Total Funding:
172.93 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Current Advisors List
Advisor
2015-01-01
Board_member
Board_member
Current Employees Featured
Pierre d’Epenoux Chief Executive Officer @ ImCheck Therapeutics
Chief Executive Officer
2016-12-01
Alem Truneh Chief Technology Officer @ ImCheck Therapeutics
Chief Technology Officer
2015-03-01
Benjamin Charles Chief Business Officer @ ImCheck Therapeutics
Chief Business Officer
2015-09-01
Rene Hoet Chief Scientific Officer @ ImCheck Therapeutics
Chief Scientific Officer
2018-10-01
Emmanuel Valentin Director Translational Medicine @ ImCheck Therapeutics
Director Translational Medicine
2019-07-01
Paul Frohna Chief Medical Officer @ ImCheck Therapeutics
Chief Medical Officer
2019-06-01
Claude Knopf Chief Business Officer @ ImCheck Therapeutics
Chief Business Officer
2020-06-01
Founder
Investors List
Pfizer Venture Investments
Pfizer Venture Investments investment in Series C - ImCheck Therapeutics
Eurazeo
Eurazeo investment in Series C - ImCheck Therapeutics
Life Sciences Partners
Life Sciences Partners investment in Series C - ImCheck Therapeutics
Wellington Partners
Wellington Partners investment in Series C - ImCheck Therapeutics
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Series C - ImCheck Therapeutics
Bpifrance
Bpifrance investment in Series C - ImCheck Therapeutics
Pureos Bioventures
Pureos Bioventures investment in Series C - ImCheck Therapeutics
Invus
Invus investment in Series C - ImCheck Therapeutics
Leukemia & Lymphoma Society
Leukemia & Lymphoma Society investment in Series C - ImCheck Therapeutics
Earlybird Venture Capital
Earlybird Venture Capital investment in Series C - ImCheck Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2020-07-09 | ImCheck Therapeutics Appoints Claude Knopf as Chief Business Officer |
Official Site Inspections
http://www.imchecktherapeutics.com Semrush global rank: 8.75 M Semrush visits lastest month: 261
- Host name: vps144.geco-it.net
- IP address: 213.32.33.73
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
